News
But three of those FDA employees told CNN that Elsa just makes up nonexistent studies, something commonly referred to in AI ...
2d
Futurism on MSNThe FDA Is Using an AI to "Speed Up" Drug Approvals and Insiders Say It's Making Horrible Mistakes
Insiders at the Food and Drug Administration are ringing alarm bells over the agency's use of an AI to fast-track drug ...
Insiders tell CNN the FDA’s AI is “hallucinating” studies and can’t access key documents. Agency leaders insist the AI is ...
Stoned AI delivers hallucinations and headaches The Trump administration is flogging artificial intelligence as the silver ...
FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.
GoodRx reports that in 2025, novel drug and biosimilar approvals lag slightly behind last year, while first generic approvals ...
2d
Que.com on MSNAI in FDA Drug Approvals Sparks Controversy Over Fabricated Studies
In recent years, Artificial Intelligence (AI) has made significant strides across various sectors, providing innovative solutions and enhancing efficiency. However, ...
3dOpinion
The New Republic on MSNRFK Jr. Is Letting AI Help Run the FDA. There’s Just One Problem
Hallucinations are a known problem with generative AI models—and Elsa is no different, according to Jeremy Walsh, the head of ...
With reports that FDA’s AI Elsa is “confidently hallucinating” studies that don’t exist, the use of AI to streamline drug ...
The FDA's generative AI, Elsa, has a massive hallucination problem, according to the agency's employees themselves.
The Food and Drug Administration's new AI tool, Elsa, is reportedly generating false studies, raising concerns about the ...
FDA's Embrace of AI to Speed Up Drug Approvals Leaves Industry Observers Excited, Uneasy 6 minute read June 06, 2025. By. ... Already, they can seek expedited approval pathways, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results